Nucleai
Nucleai61
About
Technology stack
detected 2026-07-13No comments yet. Be the first to share your take.
What does Nucleai do?
Nucleai leverages AI-powered spatial biology to advance precision medicine. Their platform enhances drug development, informs clinical treatment decisions, and aims to improve patient outcomes. They collaborate with pharmaceutical companies and license their research platform for internal use.
How much funding has Nucleai raised?
Nucleai has raised a total of $59M in funding. The most recent round on record is Series B.
Where is Nucleai headquartered?
Nucleai is headquartered in Tel Aviv, Israel.
When was Nucleai founded?
Nucleai was founded in 2018.
What industry does Nucleai operate in?
Nucleai operates in Healthcare, Oncology, Pharmaceutical, HealthTech, MedTech, Biotech.
How many employees does Nucleai have?
Nucleai has approximately 66 people on record.
What is Nucleai's revenue?
StartupHub estimates Nucleai's annual revenue at $22.8M (range $12.1M to $37.9M, 63% confidence), based on comparable companies in the sector.
What is Nucleai's valuation?
StartupHub estimates Nucleai's effective valuation at $237.0M (range $146.3M to $351.0M, 14% confidence), based on comparable companies in the sector.